Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum.

Area of Science:

• Neuroimmunology
• Neuropharmacology
• Behavioral Neuroscience

Background:

• Interferon-gamma (IFN-γ) is linked to multiple sclerosis (MS) pathogenesis and mood disturbances.
• Type-1 cannabinoid receptors (CB1Rs) are crucial in MS pathophysiology and mood regulation.
• Proinflammatory cytokines may affect neuronal activity, contributing to mood disorders in MS.

Purpose of the Study:

• To investigate the role of IFN-γ in anxiety- and depressive-like behaviors in EAE mice.
• To determine if IFN-γ modulates CB1Rs in the context of EAE and mood.
• To explore the therapeutic potential of targeting IFN-γ for mood disorders in neuroinflammation.

Main Methods:

• Biochemical, behavioral, and electrophysiological experiments in mice.
• Intracerebroventricular delivery of IFN-γ to assess mood and synaptic transmission.
• EAE induction and assessment of striatal IFN-γ expression and CB1R function.
• Pharmacological blockade of IFN-γ to evaluate rescue effects.

Main Results:

• Intracerebroventricular IFN-γ induced depressive- and anxiety-like behaviors, linked to striatal CB1R dysfunction.
• EAE mice showed increased striatal IFN-γ and impaired CB1R transmission.
• Pharmacological IFN-γ blockade rescued EAE-induced CB1R deficits.
• IFN-γ mimicked EAE's effects on CB1R function but not overall synaptic transmission in the striatum.

Conclusions:

• IFN-γ significantly influences mood control by modulating CB1R function.
• Targeting IFN-γ pathways may offer therapeutic benefits for psychological disorders in neuroinflammatory conditions like MS.
• Understanding IFN-γ's role in mood regulation is vital for developing effective treatments for MS-associated psychological comorbidities.